Literature DB >> 30460479

The incidence, indications and predictors of acute pacemaker implantation after ablation of persistent atrial fibrillation.

Verena Semmler1, Felix von Krogh2, Bernhard Haller3, Tilko Reents2, Felix Bourier2, Marta Telishevska2, Marc Kottmaier2, Marielouise Kornmayer2, Stephanie Brooks2, Katharina Koch-Büttner2, Carsten Lennerz2,4, Amir Brkic2, Christian Grebmer2, Patrick Blazek2, Severin Weigand2, Gabriele Hessling2, Christof Kolb2, Isabel Deisenhofer2.   

Abstract

INTRODUCTION: Patients with persistent atrial fibrillation (AF) may additionally suffer from a concealed sinus node disease. We sought to determine the incidence, indications and predictors of acute pacemaker [PM] implantation within 1 week after the ablation of persistent AF. METHODS AND
RESULTS: We performed a retrospective analysis of patients, who had had an ablation of persistent AF at our center. Between 01/2011 and 08/2016, 1234 patients (mean age 65 ± 10 years, 66.7% male) without prior PM implantation underwent an ablation of persistent AF. Pulmonary vein isolation (PVI) was performed in 1158 (93.8%), the additional ablation of complex fractionated atrial electrograms (CFAE) in 1109 (89.9%) and linear ablation in 524 (42.5%) patients. Temporary cardiac pacing was necessary in 27 (2.2%) patients. The temporary PM was removed in 15 patients (1.2%) because sinus node recovered after a median of 1.0 (minimum 0.1-maximum 2.0) day. The remaining 12 (1.0%) patients required the implantation of a permanent PM. Another 13 (1.1%) patients required permanent PM implantation without prior temporary pacing. In a multivariable regression model, age [OR 1.07 (1.02-1.12), p = 0.006], sinus pauses prior to ablation [OR 7.97 (2.36-26.88), p = 0.001] and atria with low voltage [OR 2.83 (1.31-6.11), p = 0.008] were identified as significant predictors for acute cardiac pacing.
CONCLUSION: Acute cardiac pacing within 1 week after the ablation of persistent AF was necessary in 40 (3.2%) patients. Age, sinus pauses in history prior to ablation and the existence of low-voltage areas in the atria were identified as relevant risk factors.

Entities:  

Keywords:  Ablation; Acute cardiac pacing; Implantation; Pacemaker; Persistent atrial fibrillation; Sinus arrest; Sinus node disease; Temporary cardiac pacing

Mesh:

Year:  2018        PMID: 30460479     DOI: 10.1007/s00392-018-1393-1

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  29 in total

1.  Prediction of sinus node dysfunction in patients with long-standing persistent atrial fibrillation using the atrial fibrillatory cycle length.

Authors:  Akinori Sairaku; Yukiko Nakano; Noboru Oda; Yuko Makita; Kenta Kajihara; Takehito Tokuyama; Chikaaki Motoda; Mai Fujiwara; Yasuki Kihara
Journal:  J Electrocardiol       Date:  2012-01-17       Impact factor: 1.438

2.  Preprocedural ventricular rate predicts subsequent sick sinus syndrome after ablation for long-standing persistent atrial fibrillation.

Authors:  Masaharu Masuda; Koichi Inoue; Katsuomi Iwakura; Atsunori Okamura; Yasushi Koyama; Ryusuke Kimura; Yuko Toyoshima; Atsushi Doi; Yohei Sotomi; Issei Komuro; Kenshi Fujii
Journal:  Pacing Clin Electrophysiol       Date:  2012-07-21       Impact factor: 1.976

3.  [Catheter ablation of persistent and long-standing persistent atrial fibrillation. Strategies and results].

Authors:  Daniel Steven; Arian Sultan; Benjamin Schäffer; Helge Servatius; Boris Hoffmann; Jakob Lüker; Stephan Willems
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-04-30

Review 4.  Catheter ablation of atrial fibrillation: state-of-the-art techniques and future perspectives.

Authors:  Pasquale Santangeli; Luigi Di Biase; David J Burkhardt; Rodney Horton; Javier Sanchez; Rong Bai; Agnes Pump; Marco Perez; Paul J Wang; Andrea Natale; Amin Al-Ahmad
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2012-02       Impact factor: 2.160

5.  Sinus node injury as a result of superior vena cava isolation during catheter ablation for atrial fibrillation and atrial flutter.

Authors:  Gang Chen; Jian Zeng Dong; Xing Peng Liu; Xin Yong Zhang; De Yong Long; Cai Hua Sang; Man Ning; Ri Bo Tang; Chen Xi Jiang; Chang Sheng Ma
Journal:  Pacing Clin Electrophysiol       Date:  2010-09-30       Impact factor: 1.976

6.  Electrophysiologic characteristics of the atrium in sinus node dysfunction: atrial refractoriness and conduction.

Authors:  A De Sisti; J F Leclercq; P Fiorello; S Manot; F Halimi; P Attuel
Journal:  J Cardiovasc Electrophysiol       Date:  2000-01

7.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Authors:  A John Camm; Paulus Kirchhof; Gregory Y H Lip; Ulrich Schotten; Irene Savelieva; Sabine Ernst; Isabelle C Van Gelder; Nawwar Al-Attar; Gerhard Hindricks; Bernard Prendergast; Hein Heidbuchel; Ottavio Alfieri; Annalisa Angelini; Dan Atar; Paolo Colonna; Raffaele De Caterina; Johan De Sutter; Andreas Goette; Bulent Gorenek; Magnus Heldal; Stefan H Hohloser; Philippe Kolh; Jean-Yves Le Heuzey; Piotr Ponikowski; Frans H Rutten
Journal:  Eur Heart J       Date:  2010-08-29       Impact factor: 29.983

8.  Pulmonary vein isolation for atrial fibrillation in patients with symptomatic sinus bradycardia or pauses.

Authors:  Yaariv Khaykin; Nassir F Marrouche; David O Martin; Walid Saliba; Robert Schweikert; Mark Wexman; Brian Strunk; Salwa Beheiry; Eduardo Saad; Mandeep Bhargava; J David Burkhardt; George Joseph; Patrick Tchou; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2004-07

9.  Evaluation of linear lesions in the left and right atrium in ablation of long-standing atrial fibrillation.

Authors:  Yuan-Long Wang; Xu Liu; Hong-Wei Tan; Li Zhou; Wei-Feng Jiang; Jun Gu; Yu-Gang Liu
Journal:  Pacing Clin Electrophysiol       Date:  2013-05-16       Impact factor: 1.976

10.  Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses.

Authors:  Mélèze Hocini; Prashanthan Sanders; Isabel Deisenhofer; Pierre Jaïs; Li-Fern Hsu; Christophe Scavée; Rukshen Weerasoriya; Florence Raybaud; Laurent Macle; Dipen C Shah; Stéphane Garrigue; Philippe Le Metayer; Jacques Clémenty; Michel Haïssaguerre
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more
  6 in total

1.  Sinus Node Dysfunction after Successful Atrial Flutter Ablation during Follow-Up: Clinical Characteristics and Predictors.

Authors:  Guan-Yi Li; Fa-Po Chung; Tze-Fan Chao; Yenn-Jiang Lin; Shih-Lin Chang; Li-Wei Lo; Yu-Feng Hu; Ta-Chuan Tuan; Jo-Nan Liao; Ting-Yung Chang; Ling Kuo; Cheng-I Wu; Chih-Min Liu; Shin-Huei Liu; Wen-Han Cheng; Shih-Ann Chen
Journal:  J Clin Med       Date:  2022-06-04       Impact factor: 4.964

Review 2.  Association between atrial fibrillation and Helicobacter pylori.

Authors:  Cecilia Tetta; Amalia Ioanna Moula; Francesco Matteucci; Orlando Parise; Bart Maesen; Daniel Johnson; Mark La Meir; Sandro Gelsomino
Journal:  Clin Res Cardiol       Date:  2019-02-08       Impact factor: 5.460

3.  Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation.

Authors:  Paweł T Matusik; Barbara Małecka; Jacek Lelakowski; Anetta Undas
Journal:  Clin Res Cardiol       Date:  2019-07-06       Impact factor: 5.460

4.  Atrial inflammation in different atrial fibrillation subtypes and its relation with clinical risk factors.

Authors:  Linghe Wu; R W Emmens; J van Wezenbeek; W Stooker; C P Allaart; A B A Vonk; A C van Rossum; H W M Niessen; P A J Krijnen
Journal:  Clin Res Cardiol       Date:  2020-02-18       Impact factor: 5.460

5.  Cryoballoon pulmonary vein isolation-mediated rise of sinus rate in patients with paroxysmal atrial fibrillation.

Authors:  Lara Wagner; Fabrice F Darche; Dierk Thomas; Patrick Lugenbiel; Panagiotis Xynogalos; Svenja Seide; Eberhard P Scholz; Hugo A Katus; Patrick A Schweizer
Journal:  Clin Res Cardiol       Date:  2020-05-13       Impact factor: 5.460

Review 6.  Pulmonary vein isolation treats symptomatic AF in a patient with Lamin A/C mutation: case report and review of the literature.

Authors:  Ann-Kathrin Rahm; Patrick Lugenbiel; Marco Ochs; Benjamin Meder; Dierk Thomas; Hugo A Katus; Eberhard Scholz
Journal:  Clin Res Cardiol       Date:  2020-03-06       Impact factor: 5.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.